Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11321894 | 0.75 | HSD17B10 (0.32) | TDP1HSD17B10 | |
| SCHEMBL4453748 | 0.74 | ALDH1A1 (0.41) | TDP1HSD17B10ALDH1A1TSHR | |
| SCHEMBL1493147 | 0.69 | HSD17B10 (0.31) | TDP1HSD17B10 | |
| Ethylene SCHEMBL27488666 | 0.69 | ALDH1A1 (0.39) | TDP1HSD17B10ALDH1A1TSHR | |
| SCHEMBL28253061 | 0.69 | ALDH1A1 (0.39) | TDP1HSD17B10ALDH1A1TSHR | |
| SCHEMBL9082807 | 0.69 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| SCHEMBL2771869 | 0.67 | ALDH1A1 (0.44) | TDP1HSD17B10ALDH1A1TSHR | |
| SCHEMBL203518 | 0.67 | ALDH1A1 (0.44) | TDP1HSD17B10ALDH1A1TSHR | |
| Methacrylic Acid SCHEMBL28675559 | 0.67 | TDP1 (0.38) | TDP1HSD17B10ALDH1A1TSHR | |
| SCHEMBL28253983 | 0.67 | ALDH1A1 (0.38) | TDP1HSD17B10ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114956653-B | Coordination activator, liquid alkali-free accelerator and preparation method and application thereof | 山西佳维新材料股份有限公司 | 2023-02-28 | — | — | CN | claimed |
| CN-114409306-B | Fluoride-free high-early-strength liquid alkali-free setting accelerator and preparation method and application thereof | 山西佳维新材料股份有限公司 | 2023-01-24 | — | — | CN | claimed |
| CN-113912321-B | Coordination activator, liquid alkali-free accelerator and preparation method and application thereof | 山西佳维新材料股份有限公司 | 2022-09-02 | — | — | CN | claimed |
| CN-114409306-A | Fluoride-free high-early-strength liquid alkali-free setting accelerator and preparation method and application thereof | 山西佳维新材料股份有限公司 | 2022-04-29 | — | — | CN | claimed |
| CN-113912321-A | Coordination activator, liquid alkali-free accelerator and preparation method and application thereof | 山西佳维新材料股份有限公司 | 2022-01-11 | — | — | CN | claimed |
| CN-113024811-A | Organic silicon tackifier, preparation method thereof and application thereof in silicone rubber | 山东特龙谱新材料有限公司 | 2021-06-25 | — | — | CN | claimed |
| CN-112811786-A | Method for recycling cold-rolled oil sludge by using cold-rolled oil sludge modifier | 武汉钢铁有限公司 | 2021-05-18 | — | — | CN | claimed |
| JP-7090083-A | — | — | None | — | — | JP | disclosed |
| US-20260118764-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM AND SILICON-CONTAINING RESIST UNDERLAYER FILM | NISSAN CHEMICAL CORPORATION (JP) | 2026-04-30 | — | — | US | disclosed |
| EP-4715465-A1 | MULTILAYER BODY, METHOD FOR PRODUCING MULTILAYER BODY, AND PHOTOSENSITIVE SURFACE MODIFIER | Nissan Chemical Corporation (JP) | 2026-03-25 | — | — | EP | disclosed |
| US-12584028-B2 | Curable organopolysiloxane composition, and optical member formed from cured product of same | DOW TORAY CO., LTD. (JP) | 2026-03-24 | — | — | US | disclosed |
| US-12585188-B2 | Composition for forming resist underlying film | NISSAN CHEMICAL CORPORATION (JP) | 2026-03-24 | — | — | US | disclosed |
| EP-4679175-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM | Nissan Chemical Corporation (JP) | 2026-01-14 | — | — | EP | disclosed |
| EP-0183493-A2 | Modified ethylenic random copolymer | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1986-06-04 | — | — | EP | disclosed |
| US-4302571-A | TERMINATED AT BOTH ENDS WITH SILANOIC HYDROXY GROUPS AND AN ORGANOSILANE OR ORGANOPOLYSILOXANE WITH HYDROLYZABLE GROUPS TO SERVE AS CROSSLINKING AGENTS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1981-11-24 | — | — | US | disclosed |
| US-4273896-A | Silylated polymers and silylated organic-organopolysiloxane block copolymers | SWS SILICONES CORPORATION (US) | 1981-06-16 | — | — | US | disclosed |
| US-4148838-A | Silylated block copolymers | SWS SILICONES CORPORATION (US) | 1979-04-10 | — | — | US | disclosed |
| US-4143089-A | SILYLATED POLYMERS | SWS SILICONES CORPORATION (US) | 1979-03-06 | — | — | US | disclosed |
| US-4080400-A | Silylated polymers and silylated organic-organopolysiloxane block copolymers | SWS SILICONES CORPORATION (US) | 1978-03-21 | — | — | US | disclosed |
| US-4066680-A | PROCESS FOR MAKING ALPHA,OMEGA-SILOXANEDIOLS | SWS SILICONES CORPORATION (US) | 1978-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260118764-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM AND SILICON-CONTAINING RESIST UNDERLAYER FILM | SRSF1, MACF1, SRPK1 | TDP1 2376/4885HSD17B10 3753/4885ALDH1A1 3642/4885 |
| US-12585188-B2 | Composition for forming resist underlying film | SRR, SMC1A, ASH2L | TDP1 3751/4885HSD17B10 953/4885ALDH1A1 1320/4885 |
| US-12584028-B2 | Curable organopolysiloxane composition, and optical member formed from cured product of same | MSR1, ILK, F12 | TDP1 4398/4885HSD17B10 2371/4885ALDH1A1 347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.